-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Avadel Pharmaceuticals Plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Avadel Pharmaceuticals Plc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $88K, a 1.12% decline year-over-year.
- Avadel Pharmaceuticals Plc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$428K, a 35.4% decline year-over-year.
- Avadel Pharmaceuticals Plc annual Income Tax Expense (Benefit) for 2023 was -$501K, a 102% decline from 2022.
- Avadel Pharmaceuticals Plc annual Income Tax Expense (Benefit) for 2022 was $26M.
- Avadel Pharmaceuticals Plc annual Income Tax Expense (Benefit) for 2021 was -$15.8M, a 30.6% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)